ライフサイエンスコーパス: drug receptor

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 cellular signal transduction and targeted as drug receptors.

2 inding can yield important information about drug-receptor and drug-drug interactions for a wide rang

3 ctural foundation for future optimization of drug-receptor binding and unbinding rates.

4 hich may be used for direct determination of drug-receptor binding interactions and for the rapid on-

5 Drug-receptor binding interactions of four agonists, ACh

6 From DNA base pairs to drug-receptor binding, hydrogen (H-)bonding and aromatic

7 ane protein, was responsible for the altered drug-receptor binding.

8 on can be partially decoupled by varying the drug-receptor dissociation rate constant, k(off), and th

9 ould also aid drug discovery by establishing drug/receptor engagement.

10 These fundamental correlations on drug-receptor H-bond interactions may be generally usefu

11 r receptor exclusively activated by designer drug) receptor hM4Di in sensorimotor cortex and AAV-expr

12 r receptor exclusively activated by designer drugs) receptor hM4di abrogated spontaneous functional r

13 ropose that HERG inactivation stabilizes the drug-receptor interaction during membrane depolarization

14 nt for activity, but its precise role in the drug-receptor interaction has not been specifically inve

15 esses its receptor in the open pore, and the drug-receptor interaction is then stabilized by inactiva

16 e molecular mechanism of this double-faceted drug-receptor interaction may help in designing new ther

17 and in determining important elements of the drug-receptor interaction.

18 mbrane receptors provide valuable models for drug-receptor interactions across many important classes

19 Modeling drug-receptor interactions at the 3D level offers consid

20 This effect of a third molecule on drug-receptor interactions cannot be studied using tradi

21 ding sites, bound conformations and specific drug-receptor interactions for several allosteric modula

22 unnatural amino acid incorporation to probe drug-receptor interactions in functional G protein-coupl

23 d with studies using rabbit aorta to examine drug-receptor interactions in vascular smooth muscle.

24 d as an important factor in protein folding, drug-receptor interactions, and catalyst selectivities.

25 cokinetics, blood-brain barrier penetration, drug-receptor interactions, heavy metal toxicity, pharma

26 variation may be secondary to differences in drug-receptor interactions, patient's compliance and tol

27 he understanding of the structural bases for drug-receptor interactions.

28 alignments from SQ are consistent with known drug-receptor interactions.

29 Drug receptor kinetics is as a key component in drug dis

30 signaling in the translational control of a drug receptor KOR, which involves the mediator of netrin

31 ontributions of F1764 and Y1771 to a complex drug receptor site in the pore of Na+ channels.

32 residues that are analogous to the mammalian drug receptor site, and the lateral pore fenestrations.

33 receptors exclusively activated by designer drugs) receptors, we enhanced Gi/o- or Gs-protein-mediat

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。